Skip to content

Study on Mood and Psychological Stress After a Single Intake of Dashi

Effects of a Single Intake of Dashi on Subjective Calmness and Psychological Stress - DASHI-STRESS Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000061407
Enrollment
35
Registered
2026-04-30
Start date
2026-04-23
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None (Healthy adults)

Interventions

After completion of a mild mental stress task, participants consume 100 mL of dashi at 60 degrees Celsius as a single oral intake, and outcome measures are assessed repeatedly before and after intake.

Sponsors

Toyo University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: - Healthy adults (male and female) aged 18 to 45 years. - Individuals who have received a full explanation of the study objectives and procedures and have provided written informed consent. - Individuals in good physical condition on the day of measurement and able to complete the study procedures without difficulty. - Individuals who are able to normally consume dashi ingredients (seafood, kelp, and mushrooms).

Exclusion criteria

Exclusion criteria: - Individuals with a history of or currently receiving treatment for cardiovascular, metabolic, neurological, or endocrine disorders. - Individuals who regularly use medications that may affect autonomic nervous system function (e.g., antihypertensive agents, anxiolytics, hypnotics/sleeping medications). - Current smokers or individuals with a habitual pattern of excessive alcohol consumption. - Individuals with taste or olfactory disorders, or with food allergies to seafood, kelp, umami seasonings, or related ingredients. - Individuals who are pregnant or breastfeeding. - Individuals reporting significant physical discomfort or poor health condition on the day of the study. - Individuals judged by the principal investigator to be unsuitable for participation in the study.

Design outcomes

Primary

MeasureTime frame
Salivary alpha-amylase measured at multiple time points before and after dashi intake

Secondary

MeasureTime frame
Heart rate variability (HRV), peripheral blood flow, blood pressure and pulse rate, and subjective measures using a visual analog scale (VAS) for calmness, anxiety, sleepiness, and fatigue.

Countries

Japan

Contacts

Public ContactNaho Serizawa

Toyo University Faculty of Health and Sports Science

serizawa@toyo.jp+81-3-5924-2819

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026